Radiation Oncology
Lim, Do Hoon
95 AppointmentProfessor & Chairman
Department of Radiation Oncology
Sungkyunkwan University School of Medicine
Speciality Interests
Schedule
05 | TUE 07 |
WEN 08 |
THU 09 |
FRI 10 |
MON 13 |
---|---|---|---|---|---|
AM | |||||
PM | available |
Medical School
2003~2005 Ph.D. in Medicine Chungbuk National University, Korea 1997~1999 Master of Science Hanyang University, Korea 1986~1990 Medical Doctor College of Medicine, Seoul National University, Korea
Specialty Training
Fellowship | 1999~2000 Department of Radiation Oncology, Seoul National University Hospital, Korea | |
---|---|---|
Residency | 1995~1999 Department of Radiation Oncology, Samsung Medical Center, Sungkyunkwan University, Korea | |
Internship | 1993~1994 Seoul National University, Korea |
Other Education
2022~Present Chief of Clinical Management Office, Samsung Medical Center
2013~Present Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2015~2019 Chief Department of Radiation Oncology, Samsung Medical Center
2008~2013 Associate Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
2001~2008 Assistant Professor Department of Radiation Oncology, Sungkyunkwan University School of Medicine
Participation in Academic Societies
and Research
2021~Present Chair Korean Society of Neuro-Oncology
2017~2018 Chair Korean Society of Pediatric Neuro-Oncology
Thesis
J BONE ONCOL 2021 10.1016/j.jbo.2021.100368
Clinical and dosimetric risk factors for vertebral compression fracture after single-fraction stereotactic body radiation therapy for spine metastases
J KOREAN MED SCI 2021 10.3346/jkms.2021.36.e128
Conditioning with 10 Gy Total Body Irradiation, Cyclophosphamide, and Fludarabine without ATG Is Associated with Improved Outcome of Cord Blood Transplantation in Children with Acute Leukemia
CANCER RES TREAT 2021 10.4143/crt.2020.756
Atypical Teratoid/Rhabdoid Tumor of the Central Nervous System in Children under the Age of 3 Years
ANN ONCOL 2021 10.1016/j.annonc.2020.11.017
A randomized phase III trial comparing adjuvant single-agent S1, S-1 with oxaliplatin, and postoperative chemoradiation with S-1 and oxaliplatin in patients with node-positive gastric cancer after D2 resection: the ARTIST 2 trial
CANCERS 2021 10.3390/cancers13010059
Impact of Radiotherapy on Kidney Function among Patients Who Received Adjuvant Treatment for Gastric Cancer: Logistic and Linear Regression Analyses